Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2006 / Cilt: 16 - Sayı: 4

Bleomisin sonrası iskemik digital gangren: Olgu sunumu

Ischemic digital gangrene after bleomycin: A case report

Pages
195–198
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We believe that the endovascular lesions on the small arterioles and capillary endothelium characteristically caused by bleomycin can cause digital ischemia finally leads to gangrene.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Case studies have indicated that bleomycin may cause ischemic ulceration and gangrene.
📊
Key Findings & Data:A 40-year old male patient suffering from pain in his left foot for a week and his fifth toe had turned black.
💡
Conclusion & Impact:We believe that the endovascular lesions on the small arterioles and capillary endothelium characteristically caused by bleomycin can cause digital ischemia finally leads to gangrene.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Toksisite testleri · Bleomisin · Gangren

Abstract

Case studies have indicated that bleomycin may cause ischemic ulceration and gangrene. A 40-year old male patient suffering from pain in his left foot for a week and his fifth toe had turned black. Three months ago, he had undergone surgery due to testicular anaplastic seminoma on his left testicle and had been given post-operative 2 cycles of bleomycin, etoposide and cisplatin chemotherapy. The fifth toe finally had to be amputated due to the progression of the gangrene. Digital ischemia can also be witnessed as a paraneoplastic syndrome in the absence of chemotherapy. We believe that the endovascular lesions on the small arterioles and capillary endothelium characteristically caused by bleomycin can cause digital ischemia finally leads to gangrene.

Özet

Bleomisinin, iskemik ülserasyon ve gangren’lere neden olabileceği literatürde vaka sunumları şeklinde bildirilmektedir. Bir haftadır devam eden sol ayakta ağrı, sol beşinci parmakta siyahlaşma şikayetleri ile hastanemize başvuran 40 yaşında erkek bir hasta sunulmaktadır. Hasta 3 ay önce sol testis testiküler anaplastik seminomu tanısı ile opere olmuş ve postoperatif 2 siklus BEP (Bleomisin, Etoposide, Cisplatin) kemoterapisi verilmişti. Gangrende, progresyon olması nedeniyle hastanın sol ayak 5. parmağı ampute edildi. Digital iskemi, kemoterapi yokluğunda paraneoplastik sendrom olarak da görülmektedir. Bununla beraber bleomisin, küçük arterıol ve kapiller endotelyal üzerinde karakteristik endovasküler lezyona yol açarak digital iskemi sonucunda gangrene yol açabilmektedir.

🔖

Cite This Article

KAYA, A. O., YILDIZ, R., YAMAN, E., BÜYÜKBERBER, S., YAMAÇ, D., ÜNER, A. (2006). Bleomisin sonrası iskemik digital gangren: Olgu sunumu. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 16 - Sayı: 4, 195–198. https://ajindex.com/articles/323059

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Correia O, Ribas F, Azevedo R, Rodrigues H, Delgado L. Gangrene of the fingertips after bleomycin and methotrexate. Cutis 66 (4): 271-272, 274, 2000
  2. Sleijfer S, Vujaskovic Z, Limburg PC, Schraffordt Koops H, Mulder NH. Induction of tumor necrosis factor-alpha as a cause of bleomycin-related toxicity. Cancer 82 (5): 970-974, 1998
  3. Caumes E, Katlama C, Guermangrez G, Bournerias I, Danıs M, Gentilini M. Cutaneous side- effects of bleomycin in AIDS patients with Kaposi’s sarcoma. Lancet 336:1593, 1990
  4. Wakefield PE, James WD, Samlaska CP, Meltzer MS. Tumor necrosis factor. J Am Acad Dermatol 24 (5): 675-685, 1991
  5. Vayssairat M, Gaitz JP, Bamberger N. Digital gangrene, HIV infection and bleomycin treatment. J Rheumatol 20 (5): 921, 1993
  6. Hladunewich M, Sawka C, Fam A, Franssen E. Raynaud’s phenomenon and digital gangrene as a consequence of treatment for Kaposi’s sarcoma. J Rheumatol 24 (12): 2371-2375, 1997
  7. Hansen SW, Olsen N, Rossing N, Rorth M. Vascular toxicity and the mechanism underlying Raynaud’s phenomenon in patients treated with cisplatin, vinblastine and bleomycin. Ann Oncol 1 (4): 289-292, 1990
  8. Cohen IS, Mosher MB, O’ Keefe MJ, Klaus SN, De Conti RC. Cutaneous toxicity of bleomycin therapy. Arch Dermatol 107 (4): 553-555, 1973
  9. Finch WR, Rodman GP,Buckingham RB, et al. Bleomycin-induced scleroderma. J Rheumatol 7 (5): 651-659, 1980.